A Double-Blind Comparison of Lisinopril with Captopril in Patients with Symptomatic Congestive Heart Failure

Eric R. Powers,Anthony Chiaramida,Anthony N. DeMaria,Thomas D. Giles,Barry Hackshaw,William Hart,Mark Haugland,Robin Johnston,Richard J. Katz,Philip C. Kirlin,Marvin McCall,Syed M. Mohiuddin,Stuart Rich,Jay M. Sullivan,Paul Wolfson,Co-Investigators

A Double-Blind Comparison of Lisinopril with Captopril in Patients with Symptomatic Congestive Heart Failure

1987

Eric R. Powers
Anthony Chiaramida
Anthony N. DeMaria
Thomas D. Giles
Barry Hackshaw
William Hart
Mark Haugland
Robin Johnston
Richard J. Katz
Philip C. Kirlin
Marvin McCall
Syed M. Mohiuddin
Stuart Rich
Jay M. Sullivan
Paul Wolfson
Co-Investigators

Angiotensin-converting enzyme (ACE) inhibition with captopril is accepted therapy for the treatment of symptomatic congestive heart failure. In this trial, we compared the new ACE inhibitor, lisinopril, to captopril during a 12-week randomized double-blind study. One hundred twenty-nine patients wit

Keywords:

Captopril
Cardiology
Lisinopril
Diabetes mellitus
Internal medicine
Symptomatic congestive heart failure
Medicine
Heart failure
Adverse effect
Efficacy
ACE inhibitor
Blood urea nitrogen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations